NCT04047095

Brief Summary

The aim of this study is to investigate the efficacy of early postoperative enteral immunonutrition on immune response and outcomes in the low operative risk cardiac surgery population with low phase angle value measured by the bioelectrical impedance analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

July 22, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 6, 2019

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

March 11, 2022

Status Verified

February 1, 2022

Enrollment Period

4.6 years

First QC Date

July 22, 2019

Last Update Submit

February 24, 2022

Conditions

Keywords

Cardiac surgeryImmunonutrition Glutamine Bioelectrical impedanceImmunological status

Outcome Measures

Primary Outcomes (6)

  • CD4+ T cell

    Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for CD4+ T cells.

    Six days

  • CD8+ T cell

    Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for CD8+ T cells.

    Six days

  • CD69+ T cell

    Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for CD69+ T cells.

    Six days

  • Interleukin-1 (IL-1)

    Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for IL-1.

    Six days

  • Interleukin-6 (IL-6)

    Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for IL-6.

    Six days

  • Tumor necrosis factor alfa (TNFα)

    Blood samples were collected twice on the surgery and on the sixth postoperative day by sampling blood for TNFα.

    Six days

Secondary Outcomes (8)

  • Acute kidney injury

    28 days

  • Stroke

    28 days

  • ICU infectious complications

    28 days

  • Duration of mechanical ventilation

    28 days

  • Retoracotomy rate

    28 days

  • +3 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Normal daily meals plus one sachet three times a day of immune nutrients for five days after the surgery. 8 a.m. - normal meal plus one sachet immune nutrients 1 p.m - normal meal plus one sachet immune nutrients 6 p.m. - normal meal plus one sachet immune nutrients

Dietary Supplement: Immunonutrients + normal daily meal

Control

ACTIVE COMPARATOR

Normal daily meals. 8 a.m. - normal meal 1 p.m. - normal meal 6 p.m. - normal meal

Dietary Supplement: Normal daily meal

Interventions

"Glutamine Plus" by Fresenius Kabi (one sachet composition: glutamine 10 g, carbohydrate 10 g, β-carotene 1.7 mg, vitamin E 83 mg, vitamin C 250 mg, zinc 3.4 mg, selenium 50 μg, and fibre 1.2 g).

Also known as: Normal daily meal (75-80 g protein)
Intervention
Normal daily mealDIETARY_SUPPLEMENT

Normal daily meal (75-80 g protein)

Control

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years;
  • Elective cardiac surgery with cardiopulmonary bypass:
  • coronary artery bypass grafting surgery (CABG);
  • aortic valve replacement;
  • mitral valve replacement;
  • mitral valve repair;
  • tricuspid valve repair;
  • combined operations (CABG and valve surgery);
  • Phase angle \<5.5⁰ (phase angle was evaluated one day prior to surgery using bioelectrical impedance analysis (InbodyS10 device).

You may not qualify if:

  • Preoperative:
  • previous cardiac surgery;
  • left ventricle ejection fraction \<40%;
  • use of preoperative intra-aortic balloon pump (IABP);
  • critical preoperative state;
  • pulmonary artery mean pressure \>55 mmHg;
  • diagnosis of infectious endocarditis;
  • pacemaker;
  • Operative:
  • complicated intraoperative course (unplanned intervention or low cardiac output syndrome in the operating theatre: failure to wean from cardiopulmonary bypass (CPB) or intraoperative insertion of IABP or infusion of two or more inotropic medications with a cumulative dose of 0.2 mcg/kg/min);
  • surgery time \>6 h;
  • unplanned intervention;
  • Postoperative:
  • disturbance of dietary rules.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vilnius University Hospital Santaros klinikos

Vilnius, 08661, Lithuania

Location

Related Publications (1)

  • Svetikiene M, Ringaitiene D, Vezeliene J, Isajevas V, Trybe D, Vicka V, Malickaite R, Jurgauskiene L, Norkuniene J, Serpytis M, Sipylaite J. The efficacy of early postoperative enteral immunonutrition on T-lymphocyte count: A randomised control study in low-risk cardiac surgery patients. Clin Nutr. 2021 Feb;40(2):372-379. doi: 10.1016/j.clnu.2020.05.009. Epub 2020 May 15.

MeSH Terms

Interventions

Proteins

Intervention Hierarchy (Ancestors)

Amino Acids, Peptides, and Proteins

Study Officials

  • Jurate Sipylaite, MD, PhD

    Vilnius University, Faculty of Medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Vilnius University Institute of Clinical Medicine Clinic of Anaesthesiology and Intensive Care

Study Record Dates

First Submitted

July 22, 2019

First Posted

August 6, 2019

Study Start

February 1, 2015

Primary Completion

September 1, 2019

Study Completion

October 1, 2021

Last Updated

March 11, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations